519MO Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis
暂无分享，去创建一个
B. Monk | Shin-ichiro Takahashi | V. Samouëlian | A. Oaknin | D. Lorusso | K. Tewari | A. Lisyanskaya | B. Maćkowiak-Matejczyk | S. Jamil | A. Cristina de Melo | C-L. Chang | F. Damian | J. Li | M. Fury | L. Polastro | M. Mathias | Y. Kim | D. Ramone | H. Kim | A. Cristina de Melo